Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

Table 2 Definition of clinical endpoints analyzed in this study

Cohort	Endpoint (bin 1/0)	Training set			Validation set
Cohort	Endpoint (bin 1/0)	# Samples	1	0	# Samples	1	0
All patients (498)	SEX	249	103	146	249	108	141
	(Female/Male)	249	103	146	249	108	141
	EFS ALL	249	89	160	249	94	155
	(Event yes/no)	249	89	160	249	94	155
	OS ALL	249	51	198	249	54	195
	(Death yes/no)	249	51	198	249	54	195
Class labeled patients (272)	CLASS LABEL	136	45	91	136	46	90
Class labeled patients (272)	(Unfavorable/Favorable)	136	45	91	136	46	90
High-risk patients (176)	EFS HR	86	55	31	90	65	25
	(Event yes/no)	86	55	31	90	65	25
	OS HR	86	43	43	90	49	41
	(Death yes/no)	86	43	43	90	49	41

ISSN: 1474-760X